Cancer Research & Education

Genentech BioOncology is dedicated to fostering future progress in anticancer innovations by sharing the latest advances in cancer research.

Click on one of our research sites below to learn more about exciting areas of cancer exploration.

  • Research ADCs

    Find out more about a new generation of antibody drug conjugates (ADCs).

  • Research Apoptosis

    Learn more about apoptosis and its role in cancer.

  • Research Bcell

    Discover the ongoing developments in B-cell malignancies and access educational resources.

  • Research BRAF

    Oncogenic BRAF signaling is implicated in diverse malignancies. Learn more about BRAF-mediated signaling and the potential of BRAF as a novel therapeutic target.

  • Research Cancer Immunotherapy

    Learn more about the potential of PD-L1 inhibition and cancer immunotherapy.

  • Research HDIs

    HER receptor dimerization is implicated in tumor growth and tumor survival in preclinical models. Learn more about dimerization's role in HER2+ breast cancer and the potential for inhibition.

  • Research HER Pathways

    Discover more about the human epidermal growth factor receptor (HER) family and its role in tumorigenesis.

  • Research MET

    The Met Pathway is dysregulated in many malignancies. Discover more about Met signaling and the potential for targeting the Met pathway in cancer.

  • Research VEGF

    Learn about the role of vascular endothelial growth factor (VEGF) in angiogenesis and its relationship to cancer.